THC Biomed Intl Ltd.
THC
CNSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -14.31% | -27.30% | -41.76% | -25.87% | -23.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.31% | -27.30% | -41.76% | -25.87% | -23.79% |
| Cost of Revenue | -6.23% | -22.60% | -38.62% | -46.44% | -39.63% |
| Gross Profit | -14.39% | 8.81% | 33.72% | 67.83% | 60.54% |
| SG&A Expenses | -12.73% | -32.29% | -33.90% | -21.95% | -10.37% |
| Depreciation & Amortization | -12.70% | -8.93% | -6.01% | -4.99% | -2.86% |
| Other Operating Expenses | -98.56% | -82.99% | -62.71% | -41.64% | -1.42% |
| Total Operating Expenses | -9.58% | -24.05% | -34.18% | -36.73% | -28.78% |
| Operating Income | 6.41% | 21.68% | 29.22% | 42.37% | 31.78% |
| Income Before Tax | -12.52% | 35.86% | 40.09% | 51.97% | 42.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.52% | 35.86% | 40.09% | 51.97% | 42.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.52% | 35.86% | 40.09% | 51.97% | 42.84% |
| EBIT | 6.41% | 21.68% | 29.22% | 42.37% | 31.78% |
| EBITDA | 15.05% | 25.18% | 33.63% | 49.51% | 32.89% |
| EPS Basic | -13.42% | 35.75% | 39.85% | 51.80% | 43.98% |
| Normalized Basic EPS | 3.67% | 20.47% | 29.17% | 42.33% | 33.94% |
| EPS Diluted | -13.42% | 35.75% | 39.85% | 51.80% | 43.98% |
| Normalized Diluted EPS | 3.67% | 20.47% | 29.17% | 42.33% | 33.94% |
| Average Basic Shares Outstanding | -0.75% | -0.69% | -0.55% | 0.07% | 2.51% |
| Average Diluted Shares Outstanding | -0.75% | -0.69% | -0.55% | 0.07% | 2.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |